drugset / Trial / NCT07266818
A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)
RandomizedParallel-groupDouble-blindBasic science
Summary
The goal of this trial is to learn about the safety of MK-1167 and if people tolerate it.
Timeline
- Start
- 2025-12-18
- Primary completion
- 2026-04-09
- Completion
- 2026-04-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-1167 | Unknown | — | Oral |
Indications
No indication recorded.